TY  - JOUR

T1  - Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party

JO  - Blood

UR  - http://dx.doi.org/10.1182/blood-2022-162277

PY  - 2022/11/15

AU  - Duque Afonso J

AU  - Finke J

AU  - Ngoya M

AU  - Galimard J-E

AU  - Craddock C

AU  - Raj K

AU  - Bloor A

AU  - Nicholson E

AU  - Eder M

AU  - Orchard KH

AU  - Valerius T et al

ED  - 

DO  - DOI: 10.1182/blood-2022-162277

PB  - American Society of Hematology

VL  - 140

IS  - Supplement 1

SP  - 2110

EP  - 2112

Y2  - 2024/12/22

ER  -